Contribution of host immunity to cyclophosphamide therapy of a chemically‐induced murine sarcoma
- 15 March 1973
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 11 (2), 358-368
- https://doi.org/10.1002/ijc.2910110213
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- DEMONSTRATION OF CELL‐SURFACE ANTIGENS ON CHEMICALLY INDUCED TUMORS*Annals of the New York Academy of Sciences, 1971
- Host defence mechanisms in Burkitt's lymphoma and Kaposi's sarcoma: the clinical evidence.BMJ, 1970
- The influence of host factors on cyclophosphamide treatment of Moloney virus-induced lymphomasEuropean Journal of Cancer (1965), 1970
- Immunotherapy of primary moloney sarcoma-virus-induced tumorsInternational Journal of Cancer, 1970
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- In vitro studies of immune reactions against autochthonous and syngeneic mouse tumors induced by methylcholanthrene and plastic discsInternational Journal of Cancer, 1968
- Duration of Drug Levels in Mice as Indicated by Residual Antileukemic EfficacyChemotherapy, 1968
- Relationship Between Tumor Incompatibility and Therapeutic Response.Experimental Biology and Medicine, 1967
- Antitumor Effects of Kethoxal-Bis(Thiosemicarbazone) and 6-Mercaptopurine in Neonatally Thymeetomized Mice.Experimental Biology and Medicine, 1967
- Prolongation of Homograft Survival in Mice with Single Doses of CyclophosphamideNature, 1963